Health & Personal Care Recalls

Philips IntelliVue MP60 Recall for Alarm Failure Affects 1,913,441 Monitors (2025)

Philips North America is recalling 1,913,441 IntelliVue MP60 patient monitors. The monitors may fail to alarm as designed. Hospitals and clinics using MP60 units should stop using the devices and follow the recall instructions.

Nivagen Zinc Oxide Ointment Recalled Due to cGMP Deviations

Dynarex Recalls Wecare Calasoothe Ointment Over cGMP Violations

Nivagen Zinc Oxide Ointment Recall 912 Containers Over cGMP Deviations (2025)

STRYKER NICO Myriad Handpiece Recall for 39,148 Units Worldwide (2026)

Tape used to secure components within packaging contains latex, despite products being labeled as latex-free. Latex could potentially cause an allergic reaction.

Stryker MV3 Bariatric Bed Recalled Over Compatibility Issues

Stryker Medical recalled 286 MV3 bariatric beds on October 31, 2025. The beds may not be compatible with Arise 1000EX mattresses, posing risks to patients. Healthcare providers and patients must stop using the beds immediately.

Aizu Olympus OER-Elite Medical Device Recall Affects 6,578 US Units (2025)

Philips IntelliVue MX700 Recall Affects 1,913,441 Monitors Worldwide (2025)

Potential issue where the IntelliVue monitors did not alarm.

Cipla Recalls Phytonadione Injectable Emulsion Due to Stability Issues

Failed Stability Specifications: Observed OOS results: eg results for colour index

Olympus HX-400U-30 Recall: 7,803 Endoscopic Ligation Devices Recalled in 2025

Potential that the ligation loop was unable to release or detach as expected during use, causing the loop to become unintentionally fixed around patient anatomy.

B. Braun Medical Infusomat IV Sets Recalled for Backflow and Occlusion Risk (49,330,370 Units)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical Recalls 3,120 IV Administration Sets for Infusomat Pumps in 2025

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 66,792 Units for Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 122,232 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical IV Administration Set Recall 36,936 Units for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 45,288 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 98,568 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall for 5,952 Units Over Backflow Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B. Braun Medical IV Administration Set Recall 2025 Affects 259,392 Units

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).

B Braun Medical Recalls 12,168 IV Administration Sets for Backflow and Occlusion Risk (2025)

Potential for backflow of medication from secondary (piggyback) IV containers into primary IV containers and the inability to prime (occlusion).